These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9851817)

  • 1. Polyethyleneglycol-stabilized manganese-substituted hydroxylapatite as a potential contrast agent for magnetic resonance imaging: particle stability in biologic fluids.
    Fallis S; Beaty-Nosco J; Dorshow RB; Adzamli K
    Invest Radiol; 1998 Dec; 33(12):847-52. PubMed ID: 9851817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of polyethyleneglycol-stabilized, manganese-substituted hydroxylapatite (MnHA-PEG). A potential MR blood pool agent.
    Adzamli K; Dorshow RB; Hynes MR; Nosco DL; Adams MD
    Acta Radiol Suppl; 1997; 412():73-8. PubMed ID: 9240084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evaluation of a polyethyleneglycol-stabilized manganese-substituted hydroxylapatite as an intravascular contrast agent for MR angiography.
    Adzamli K; Dorshow RB; Hynes MR; Li D; Nosco DL; Adams MD
    J Magn Reson Imaging; 1997; 7(1):204-8. PubMed ID: 9039616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese-substituted hydroxyapatites coated with polyethylene glycol diphosphonate: potential blood-pool agents for magnetic resonance imaging.
    Adzamli K; Dorshow RB; Hynes MR; Nosco DL; Beaty-Nosco JA; Fallis S; Galen KP; Levine JA; Nema S; Polta J; Adams MD
    Acad Radiol; 1996 Aug; 3 Suppl 2():S349-52. PubMed ID: 8796601
    [No Abstract]   [Full Text] [Related]  

  • 5. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
    Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.
    Zhan Y; Zhan W; Li H; Xu X; Cao X; Zhu S; Liang J; Chen X
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29231865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and in vitro cellular uptake of PEG coated iron oxide nanoparticles as MRI contrast agent.
    Chen YJ; Tao J; Xiong F; Zhu JB; Gu N; Geng KK
    Pharmazie; 2010 Jul; 65(7):481-6. PubMed ID: 20662315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum.
    Moghimi SM; Muir IS; Illum L; Davis SS; Kolb-Bachofen V
    Biochim Biophys Acta; 1993 Nov; 1179(2):157-65. PubMed ID: 8218358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manganese hydroxylapatite as a potential magnetic resonance contrast agent for liver imaging.
    Braddock-Wilking J; Nosco DL; Hynes MR; Galen KP; Dorshow RB; Adams MD
    Invest Radiol; 1994 Jun; 29 Suppl 2():S251-4. PubMed ID: 7928248
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
    Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
    Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
    Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
    Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agent.
    Masoudi A; Madaah Hosseini HR; Shokrgozar MA; Ahmadi R; Oghabian MA
    Int J Pharm; 2012 Aug; 433(1-2):129-41. PubMed ID: 22579990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of systems for targeting the regional lymph nodes for diagnostic imaging: in vivo behaviour of colloidal PEG-coated magnetite nanospheres in the rat following interstitial administration.
    Illum L; Church AE; Butterworth MD; Arien A; Whetstone J; Davis SS
    Pharm Res; 2001 May; 18(5):640-5. PubMed ID: 11465419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some characteristics of hydroxylapatite powder particles after plasma spraying.
    Pálka V; Postrková E; Koerten HK
    Biomaterials; 1998 Oct; 19(19):1763-72. PubMed ID: 9856587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of diethylenetriaminepentaacetic acid-manganese(II) complexes modified by narrow molecular weight distribution of chitosan oligosaccharides as potential magnetic resonance imaging contrast agents.
    Huang Y; Zhang X; Zhang Q; Dai X; Wu J
    Magn Reson Imaging; 2011 May; 29(4):554-60. PubMed ID: 21277723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent.
    Nitin N; LaConte LE; Zurkiya O; Hu X; Bao G
    J Biol Inorg Chem; 2004 Sep; 9(6):706-12. PubMed ID: 15232722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diblock-copolymer-mediated self-assembly of protein-stabilized iron oxide nanoparticle clusters for magnetic resonance imaging.
    Tähkä S; Laiho A; Kostiainen MA
    Chemistry; 2014 Mar; 20(10):2718-22. PubMed ID: 24523066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mn12 single-molecule magnet aggregates as magnetic resonance imaging contrast agents.
    Wang Y; Li W; Zhou S; Kong D; Yang H; Wu L
    Chem Commun (Camb); 2011 Mar; 47(12):3541-3. PubMed ID: 21327273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pH-activatable nanoparticle with signal-amplification capabilities for non-invasive imaging of tumour malignancy.
    Mi P; Kokuryo D; Cabral H; Wu H; Terada Y; Saga T; Aoki I; Nishiyama N; Kataoka K
    Nat Nanotechnol; 2016 Aug; 11(8):724-30. PubMed ID: 27183055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatible KMnF3 nanoparticular contrast agent with proper plasma retention time for in vivo magnetic resonance imaging.
    Liu ZJ; Song XX; Xu XZ; Tang Q
    Nanotechnology; 2014 Apr; 25(15):155101. PubMed ID: 24642699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.